Onco Therapies Limited - Company Profile

It is a chemicals public limited company based in Hyderabad, Telangana, India, established in 2007.
2007 Hyderabad, Telangana, India Amalgamated
Last Updated:
Access Report
About Onco Therapies Limited

Onco Therapies Limited, a amalgamated public limited company, was established on 14 August 2007 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232TG2007PLC093716. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.41 Cr.

Its leadership includes Susanto Banerjee (Additional Director), Rajeev Mukundan (Additional Director), Sanjeev Kumar Sethi (Additional Director). Past directors included Venkataraman Subramanian Iyer, Peter Harvey Gibb, Christopher Stubbs. Its latest AGM occurred on 07 June 2013, with the balance sheet filed on 31 December 2012. It is based at Plot No.564/A/22 Road No.92, Jubilee Hills, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2007PLC093716

  • Registration Number

    093716

  • Incorporation Date

    14 August 2007

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.41 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.41 Cr
  • Company Age 18 Year, 6 Months
  • Last Filing with ROC 31 Dec 2012
Company report

Onco Therapies Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Onco Therapies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Onco Therapies Limited?
Current Directors
Name Designation Appointment Date Status
Susanto Banerjee Additional Director 05 Dec 2013 Current
Rajeev Mukundan Additional Director 05 Dec 2013 Current
Sanjeev Kumar Sethi Additional Director 05 Dec 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Dec 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2008 Past
Pramod Abcsdd Director 19 Feb 2009 Past
Pramod Abcsdd Director 04 May 2011 Past
Pramod Abcsdd Director 10 Mar 2008 Past
Pramod Abcsdd Additional Director 27 May 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Onco Therapies.

Enhance accessibility to Onco Therapies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Onco Therapies revenue growth over time
Onco Therapies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Onco Therapies?

Unlock access to Onco Therapies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Onco Therapies?

Unlock and access historical data on people associated with Onco Therapies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Onco Therapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onco Therapies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Onco Therapies
Recent Activity within the Organization
  • Director Appointment

    Susanto Banerjee was appointed as a Additional Director was appointed as a Additional Director on 05 Dec 2013 & has been associated with this company since 12 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Rajeev Mukundan was appointed as a Additional Director was appointed as a Additional Director on 05 Dec 2013 & has been associated with this company since 12 years 2 months . was completed.

  • Director Appointment

    Progress on Sanjeev Kumar Sethi was appointed as a Additional Director was appointed as a Additional Director on 05 Dec 2013 & has been associated with this company since 12 years 2 months . was documented.

  • Annual General Meeting

    Onco Therapies Limited last Annual general meeting of members was held on 07 Jun 2013 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Onco Therapies Limited has filed its annual Financial statements for the year ended 31 Dec 2012 with Roc Hyderabad. was recorded as a recent event.

  • Company Incorporation

    Progress on Onco Therapies Limited was registered on 14 Aug 2007 with Roc Hyderabad & aged 18 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Onco Therapies Limited?

The CIN of Onco Therapies Limited is U24232TG2007PLC093716.

Where is Onco Therapies Limited headquartered?

Onco Therapies Limited is headquartered at Plot No.564/A/22 Road No.92, Jubilee Hills, Hyderabad, Telangana, 500034.

When was Onco Therapies Limited incorporated?

Onco Therapies Limited was incorporated on 14 August 2007.

Who are the current directors of Onco Therapies Limited?

The current directors of Onco Therapies Limited are

What is the primary industry of Onco Therapies Limited?

The primary industry of Onco Therapies Limited is Chemicals.

Is Onco Therapies Limited a listed company?

Onco Therapies Limited is unlisted.

What is the capital structure of Onco Therapies Limited?

The authorized capital of Onco Therapies Limited is ₹3.00 Cr, and the paid-up capital is ₹2.41 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available